Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Long-Chain Acyl-CoA Synthetase 1 Role in Sepsis and Immunity: Perspectives From a Parallel Review of Public Transcriptome Datasets and of the Literature.

Roelands J, Garand M, Hinchcliff E, Ma Y, Shah P, Toufiq M, Alfaki M, Hendrickx W, Boughorbel S, Rinchai D, Jazaeri A, Bedognetti D, Chaussabel D.

Front Immunol. 2019 Oct 18;10:2410. doi: 10.3389/fimmu.2019.02410. eCollection 2019. Review.

2.

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod.

Rozenblit M, Hendrickx W, Heguy A, Chiriboga L, Loomis C, Ray K, Darvishian F, Egeblad M, Demaria S, Marincola FM, Bedognetti D, Adams S.

Sci Rep. 2019 Jun 12;9(1):8572. doi: 10.1038/s41598-019-42784-9.

3.

Identifying factors associated with sedentary time after stroke. Secondary analysis of pooled data from nine primary studies.

Hendrickx W, Riveros C, Askim T, Bussmann JBJ, Callisaya ML, Chastin SFM, Dean CM, Ezeugwu VE, Jones TM, Kuys SS, Mahendran N, Manns TJ, Mead G, Moore SA, Paul L, Pisters MF, Saunders DH, Simpson DB, Tieges Z, Verschuren O, English C.

Top Stroke Rehabil. 2019 Jul;26(5):327-334. doi: 10.1080/10749357.2019.1601419. Epub 2019 Apr 26.

PMID:
31025908
4.

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer.

Bertucci F, Finetti P, Simeone I, Hendrickx W, Wang E, Marincola FM, Viens P, Mamessier E, Ceccarelli M, Birnbaum D, Bedognetti D.

Br J Cancer. 2018 Nov;119(11):1383-1391. doi: 10.1038/s41416-018-0309-1. Epub 2018 Oct 24.

5.

Immune oncology, immune responsiveness and the theory of everything.

Turan T, Kannan D, Patel M, Matthew Barnes J, Tanlimco SG, Lu R, Halliwill K, Kongpachith S, Kline DE, Hendrickx W, Cesano A, Butterfield LH, Kaufman HL, Hudson TJ, Bedognetti D, Marincola F, Samayoa J.

J Immunother Cancer. 2018 Jun 5;6(1):50. doi: 10.1186/s40425-018-0355-5.

6.

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.

Thomas R, Al-Khadairi G, Roelands J, Hendrickx W, Dermime S, Bedognetti D, Decock J.

Front Immunol. 2018 May 1;9:947. doi: 10.3389/fimmu.2018.00947. eCollection 2018. Review.

7.

Exercise interventions in healthy older adults with sarcopenia: A systematic review and meta-analysis.

Vlietstra L, Hendrickx W, Waters DL.

Australas J Ageing. 2018 Sep;37(3):169-183. doi: 10.1111/ajag.12521. Epub 2018 Apr 11.

PMID:
29638028
8.

A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification.

Roelands J, Decock J, Boughorbel S, Rinchai D, Maccalli C, Ceccarelli M, Black M, Print C, Chou J, Presnell S, Quinn C, Jithesh P, Syed N, Al Bader SBJ, Bedri S, Wang E, Marincola FM, Chaussabel D, Kuppen P, Miller LD, Bedognetti D, Hendrickx W.

Version 2. F1000Res. 2017 Mar 20 [revised 2018 Jan 1];6:296. doi: 10.12688/f1000research.10960.2. eCollection 2017.

9.

Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.

Roelands J, Kuppen PJK, Vermeulen L, Maccalli C, Decock J, Wang E, Marincola FM, Bedognetti D, Hendrickx W.

Int J Mol Sci. 2017 Oct 24;18(10). pii: E2229. doi: 10.3390/ijms18102229. Review.

10.

Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells.

Orecchioni M, Bedognetti D, Newman L, Fuoco C, Spada F, Hendrickx W, Marincola FM, Sgarrella F, Rodrigues AF, Ménard-Moyon C, Cesareni G, Kostarelos K, Bianco A, Delogu LG.

Nat Commun. 2017 Oct 24;8(1):1109. doi: 10.1038/s41467-017-01015-3.

11.

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients.

Maccalli C, Giannarelli D, Chiarucci C, Cutaia O, Giacobini G, Hendrickx W, Amato G, Annesi D, Bedognetti D, Altomonte M, Danielli R, Calabrò L, Di Giacomo AM, Marincola FM, Parmiani G, Maio M.

Oncoimmunology. 2017 May 8;6(7):e1323618. doi: 10.1080/2162402X.2017.1323618. eCollection 2017.

12.

Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.

Hendrickx W, Simeone I, Anjum S, Mokrab Y, Bertucci F, Finetti P, Curigliano G, Seliger B, Cerulo L, Tomei S, Delogu LG, Maccalli C, Wang E, Miller LD, Marincola FM, Ceccarelli M, Bedognetti D.

Oncoimmunology. 2017 Feb 6;6(2):e1253654. doi: 10.1080/2162402X.2016.1253654. eCollection 2017.

13.

Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.

Miller LD, Chou JA, Black MA, Print C, Chifman J, Alistar A, Putti T, Zhou X, Bedognetti D, Hendrickx W, Pullikuth A, Rennhack J, Andrechek ER, Demaria S, Wang E, Marincola FM.

Cancer Immunol Res. 2016 Jul;4(7):600-10. doi: 10.1158/2326-6066.CIR-15-0149. Epub 2016 Apr 28.

14.

Disentangling the relationship between tumor genetic programs and immune responsiveness.

Bedognetti D, Hendrickx W, Ceccarelli M, Miller LD, Seliger B.

Curr Opin Immunol. 2016 Apr;39:150-8. doi: 10.1016/j.coi.2016.02.001. Epub 2016 Mar 9. Review.

PMID:
26967649
15.

Prognostic and predictive immune gene signatures in breast cancer.

Bedognetti D, Hendrickx W, Marincola FM, Miller LD.

Curr Opin Oncol. 2015 Nov;27(6):433-44. doi: 10.1097/CCO.0000000000000234. Review.

PMID:
26418235
16.

Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.

Decock J, Hendrickx W, Thirkettle S, Gutiérrez-Fernández A, Robinson SD, Edwards DR.

Breast Cancer Res. 2015 Mar 14;17:38. doi: 10.1186/s13058-015-0545-8.

17.

Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 Cells.

Hendrickx W, Decock J, Mulholland F, Bao Y, Fairweather-Tait S.

Front Oncol. 2013 Sep 23;3:239. doi: 10.3389/fonc.2013.00239. eCollection 2013.

18.

Short-Term Prognostic Index for Breast Cancer: NPI or Lpi.

Van Belle V, Decock J, Hendrickx W, Brouckaert O, Pintens S, Moerman P, Wildiers H, Paridaens R, Christiaens MR, Van Huffel S, Neven P.

Patholog Res Int. 2010 Dec 28;2011:918408. doi: 10.4061/2011/918408.

19.

Relationship between age and axillary lymph node involvement in women with breast cancer.

Wildiers H, Van Calster B, van de Poll-Franse LV, Hendrickx W, Røislien J, Smeets A, Paridaens R, Deraedt K, Leunen K, Weltens C, Van Huffel S, Christiaens MR, Neven P.

J Clin Oncol. 2009 Jun 20;27(18):2931-7. doi: 10.1200/JCO.2008.16.7619. Epub 2009 May 18.

PMID:
19451448
20.

Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer.

Decock J, Obermajer N, Vozelj S, Hendrickx W, Paridaens R, Kos J.

Int J Biol Markers. 2008 Jul-Sep;23(3):161-8.

PMID:
18949742
21.

Clinicopathological features of inflammatory versus noninflammatory locally advanced nonmetastatic breast cancer.

Brouwers B, Paridaens R, Lobelle JP, Hendrickx W, Smeets A, Neven P, Weltens C, Deraedt K, Vanden Bempt I, Christiaens MR, Wildiers H.

Tumour Biol. 2008;29(4):211-6. doi: 10.1159/000152938. Epub 2008 Sep 9.

PMID:
18781092
22.

Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.

Brouckaert O, Pintens S, Van Belle V, Van Huffel S, Camerlynck E, Amant F, Leunen K, Smeets A, Berteloot P, Van Limbergen E, Decock J, Hendrickx W, Weltens C, Van den Bogaert W, Vanden Bempt I, Drijkoningen M, Paridaens R, Wildiers H, Vergote I, Christiaens MR, Neven P.

Breast Cancer Res Treat. 2009 May;115(2):349-58. doi: 10.1007/s10549-008-0110-6. Epub 2008 Jul 16.

PMID:
18629635
23.

In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement.

Neven P, Brouckaert O, Van Belle V, Vanden Bempt I, Hendrickx W, Cho H, Deraedt K, Van Calster B, Van Huffel S, Moerman P, Amant F, Leunen K, Smeets A, Wildiers H, Paridaens R, Vergote I, Christiaens MR.

J Clin Oncol. 2008 Apr 1;26(10):1768-9; author reply 1769-71. doi: 10.1200/JCO.2007.15.6141. No abstract available.

PMID:
18519273
24.

Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis.

Decock J, Hendrickx W, Vanleeuw U, Van Belle V, Van Huffel S, Christiaens MR, Ye S, Paridaens R.

BMC Cancer. 2008 Mar 20;8:77. doi: 10.1186/1471-2407-8-77.

25.

Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.

Van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, Van Huffel S, Hendrickx W, Decock J, Huang HJ, Leunen K, Amant F, Berteloot P, Paridaens R, Wildiers H, Van Limbergen E, Weltens C, Timmerman D, Van Gorp T, Smeets A, Van den Bogaert W, Vergote I, Christiaens MR, Neven P.

Breast Cancer Res Treat. 2009 Jan;113(1):181-7. doi: 10.1007/s10549-008-9914-7. Epub 2008 Feb 9.

PMID:
18264760
26.

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

De Maeyer L, Van Limbergen E, De Nys K, Moerman P, Pochet N, Hendrickx W, Wildiers H, Paridaens R, Smeets A, Christiaens MR, Vergote I, Leunen K, Amant F, Neven P.

J Clin Oncol. 2008 Jan 10;26(2):335-6; author reply 336-8. doi: 10.1200/JCO.2007.14.8411. No abstract available.

PMID:
18182677
27.

Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.

Decock J, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W, Pearce EG, Gao YT, Pereira AC, Paridaens R, Zheng W, Ye S.

Cancer Res. 2007 Nov 1;67(21):10214-21.

28.

Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.

Neven P, Van Calster B, Van den Bempt I, Van Huffel S, Van Belle V, Hendrickx W, Decock J, Wildiers H, Paridaens R, Amant F, Leunen K, Berteloot P, Timmerman D, Van Limbergen E, Weltens C, Van den Bogaert W, Smeets A, Vergote I, Christiaens MR, Drijkoningen M.

Breast Cancer Res Treat. 2008 Jul;110(1):153-9. Epub 2007 Aug 9.

PMID:
17687649
29.

Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.

Decock J, Hendrickx W, Drijkoningen M, Wildiers H, Neven P, Smeets A, Paridaens R.

Dis Markers. 2007;23(3):189-96.

30.

Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age.

Van Mieghem T, Leunen K, Pochet N, De Moor B, De Smet F, Amant F, Berteloot P, Timmerman D, Vanden Bempt I, Drijkoningen R, Wildiers H, Paridaens R, Smeets A, Hendrickx W, Van Limbergen E, Christiaens MR, Vergote I, Neven P.

Breast Cancer Res Treat. 2007 Nov;106(1):127-33. Epub 2007 Jan 9.

PMID:
17211534
31.

Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables.

Decock J, Hendrickx W, Wildiers H, Christiaens MR, Neven P, Drijkoningen M, Paridaens R.

Clin Exp Metastasis. 2005;22(6):495-502.

PMID:
16320112
32.

Colonization of rabbits with Staphylococcus aureus in flocks with and without chronic staphylococcosis.

Hermans K, De Herdt P, Devriese LA, Hendrickx W, Godard C, Haesebrouck F.

Vet Microbiol. 1999 Jun 1;67(1):37-46.

PMID:
10392776
33.

A new pathogenic Staphylococcus aureus type in commercial rabbits.

Devriese LA, Hendrickx W, Godard C, Okerman L, Haesebrouck F.

Zentralbl Veterinarmed B. 1996 Jul;43(5):313-5.

PMID:
8779813
34.

Primary pathogenicity of an European isolate of Chlamydia psittaci from turkey poults.

Vanrompay D, Ducatelle R, Haesebrouck F, Hendrickx W.

Vet Microbiol. 1993 Dec;38(1-2):103-13.

PMID:
8128594

Supplemental Content

Loading ...
Support Center